AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 10 - (NewsRx.com & NewsRx.net) -- The International AIDS Vaccine Initiative (IAVI) has begun human trials in South Africa and Switzerland to test HIVA.MVA, a candidate vaccine to prevent people uninfected with HIV/AIDS from contracting the disease.
This brings to five the number of countries where this vaccine candidate currently is in trials.
In South Africa, HIVA.MVA is the second preventive AIDS vaccine candidate to begin a trial in the country this month. The trial of HIVA.MVA is being conducted at the Chris Hani Baragwanath Hospital in Soweto and the Medical Research Council in Durban. AIDS vaccine research in South Africa is coordinated by the South African AIDS Vaccine Initiative.
In Switzerland, the trial of HIVA.MVA is being conducted at the University of Lausanne.
HIVA.MVA is designed as a preventive vaccine. It is intended to protect people uninfected with HIV/AIDS from contracting the disease. HIVA.MVA uses a vaccine design ...
Source: HighBeam Research, AIDS vaccine trials begin in South Africa, Switzerland.